| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9422 |
| Human Intestinal Absorption | HIA+ | 0.9751 |
| Caco-2 Permeability | Caco2+ | 0.7014 |
| P-glycoprotein Substrate | Substrate | 0.5000 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6918 |
| Non-inhibitor | 0.7542 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8464 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8745 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8547 |
| CYP450 2D6 Substrate | Non-substrate | 0.8752 |
| CYP450 3A4 Substrate | Non-substrate | 0.5541 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6798 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8072 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8484 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6324 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7759 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6898 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8904 |
| Non-inhibitor | 0.7354 |
| AMES Toxicity | Non AMES toxic | 0.9364 |
| Carcinogens | Non-carcinogens | 0.7249 |
| Fish Toxicity | High FHMT | 0.9924 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9999 |
| Honey Bee Toxicity | High HBT | 0.5633 |
| Biodegradation | Ready biodegradable | 0.6079 |
| Acute Oral Toxicity | IV | 0.7807 |
| Carcinogenicity (Three-class) | Warning | 0.5422 |